APAC Liquid Biopsy Market - Industry Trends and Forecast to 2030
The Asia-Pacific liquid biopsy market is expected to reach USD 701.06 million by 2030 from USD 274.42 million in 2022, growing at a CAGR of 13.4% during the forecast period of 2023 to 2030.
Market Segmentation:Asia-Pacific Liquid Biopsy Market, By Product (Instruments, Consumables & Accessories, Services & Software), Biomarker Type (Circulating Tumor Cells (CTCS), Circulating Cell-Free DNA (CFDNA), Cell-free RNA, Extracellular Vesicles, Exosomes, and Others), Sample Type (Blood Sample Based, Urine Sample Based, Saliva & Other Tissue Fluid Sample-Based, and Others), Analytical Type (Molecular, Proteomics, and Histology/Imaging), Application Type (Cancer Applications and Non-Cancer Applications), Clinical Application (Routine Screening, Patient Work-Up, Therapy Selection, Treatment Monitoring, Recurrence Monitoring, and Others), Technology (Multi-Gene Parallel Analysis, and Single-Gene Analysis), End User (Hospitals, Reference Laboratories, Diagnostic Centers, Research Centers & Academic Institutes, and Others), Distribution Channel (Direct Tender, Third Party Distributor, and Others), Country (Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2030
Overview of Asia-Pacific Liquid Biopsy Market Dynamics:Driver
• Technological advancements in liquid biopsy platforms
Restrain
• Lack of standardized guidelines
Opportunity
• Increasing reimbursements and government support for liquid biopsy
Market Players:Some of the key market players operating in the Asia-Pacific liquid biopsy market are listed below: • F. Hoffmann-La Roche Ltd
• Guardant Health
• Thermo Fisher Scientific Inc.
• Exact Sciences Corporation (Genomic health)
• QIAGEN
• Labcorp
• Johnson & Johnson Services, Inc.
• Illumina Inc
• NeoGenomics Laboratories
• Bio-Rad Laboratories, Inc.
• Natera, Inc.
• CARDIFF ONCOLOGY, INC.
• Sysmex Inostics Inc.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.